Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness & Safety of Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy: A Randomized Controlled Trial

NCT06224790 is registered in ClinicalTrials.gov with Sidrah Lodhi as lead sponsor.

NCT NCT06224790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06224790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness & Safety of Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy: A Randomized Controlled Trial
Lead sponsor
Sidrah Lodhi
Phase
Phase 4
Overall status
Completed
Start date
March 10, 2024
Completion date
March 7, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathies, type 2 diabetes